NFKB1 and glioblastoma: Because GBM is known for resistance to therapy with temozolomide, a process mediated through NF-kB overexpression (Lavon et al., 2007), Wu et al. investigated whether a combination of curcumin and TMZ would improve GBM chemosensitivity.